1. Volume 76, Pages S50-S99 (August 2009)
Chapter 4.1: Treatment of CKD–MBD targeted at lowering high serum phosphorus and maintaining serum calcium 
Kidney International 
Volume 76, Pages S50-S99 (August 2009)
DOI: /ki
Copyright © 2009 International Society of Nephrology Terms and Conditions

2. Figure 15
Comparison of PTH levels to underlying bone histology in chronic hemodialysis patients. Intact PTH levels <150 pg/ml presented a 50% sensitivity, an 85% specificity, and an 83% positive predictive value for the diagnosis of low bone turnover (LT). In contrast, iPTH levels>300 pg/ml presented a 69% sensitivity, a 75% specificity, and a 62% positive predictive value for the diagnosis of high bone turnover (HT). iPTH, intact parathyroid hormone; n, number of patients; NL, normal bone turnover. Reprinted with permission from Barreto et al.229
Kidney International  , S50-S99DOI: ( /ki )
Copyright © 2009 International Society of Nephrology Terms and Conditions

3. Figure 16
Risk of all-cause mortality associated with combinations of baseline serum phosphorus and calcium categories by PTH level. HR, hazard ratio; PTH, parathyroid hormone. Reprinted with permission from Tentori et al.33
Kidney International  , S50-S99DOI: ( /ki )
Copyright © 2009 International Society of Nephrology Terms and Conditions

4. Kidney International 2009 76, S50-S99DOI: (10.1038/ki.2009.192)
Copyright © 2009 International Society of Nephrology Terms and Conditions

5. Kidney International 2009 76, S50-S99DOI: (10.1038/ki.2009.192)
Copyright © 2009 International Society of Nephrology Terms and Conditions

6. Kidney International 2009 76, S50-S99DOI: (10.1038/ki.2009.192)
Copyright © 2009 International Society of Nephrology Terms and Conditions

7. Kidney International 2009 76, S50-S99DOI: (10.1038/ki.2009.192)
Copyright © 2009 International Society of Nephrology Terms and Conditions